ProfileGDS4718 / 244542_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 28% 26% 26% 27% 20% 30% 24% 31% 29% 29% 27% 23% 25% 27% 29% 23% 26% 23% 20% 27% 20% 23% 25% 21% 21% 24% 20% 22% 27% 24% 27% 20% 22% 32% 17% 22% 28% 28% 24% 23% 25% 18% 19% 24% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4667828
GSM549102patient 115, normal, homogenized [OPG study]4.3774126
GSM549104patient 119, normal, homogenized [OPG study]4.3401426
GSM549108patient 138, normal, homogenized [OPG study]4.4731727
GSM549119patient 077, normal, homogenized [OPG study]4.14120
GSM549133patient 032, cancer, homogenized [OPG study]4.4874830
GSM549139patient 042, cancer, homogenized [OPG study]4.2742124
GSM549099patient 107, normal, homogenized [OPG study]4.621231
GSM549109patient 139, normal, homogenized [OPG study]4.5364829
GSM549110patient 046, normal, homogenized [OPG study]4.5102329
GSM549114patient 063, normal, homogenized [OPG study]4.3866927
GSM549122patient 082, normal, homogenized [OPG study]4.276523
GSM549134patient 033, cancer, homogenized [OPG study]4.3364625
GSM549136patient 036, cancer, homogenized [OPG study]4.3553927
GSM549140patient 044, cancer, homogenized [OPG study]4.450629
GSM549111patient 047, normal, homogenized [OPG study]4.2173323
GSM549113patient 057, normal, homogenized [OPG study]4.3077826
GSM549132patient 031, cancer, homogenized [OPG study]4.251823
GSM549137patient 038, cancer, homogenized [OPG study]4.135620
GSM549142patient 047, cancer, homogenized [OPG study]4.5378427
GSM549100patient 110, normal, homogenized [OPG study]4.1512720
GSM549107patient 135, normal, homogenized [OPG study]4.2083723
GSM549115patient 068, normal, homogenized [OPG study]4.2957225
GSM549116patient 072, normal, homogenized [OPG study]4.1692521
GSM549120patient 078, normal, homogenized [OPG study]4.167621
GSM549131patient 030, cancer, homogenized [OPG study]4.2544524
GSM549118patient 074, normal, homogenized [OPG study]4.147420
GSM549129patient 027, cancer, homogenized [OPG study]4.2377422
GSM549123patient 088, normal, homogenized [OPG study]4.4179627
GSM549124patient 006, cancer, homogenized [OPG study]4.3423524
GSM549126patient 015, cancer, homogenized [OPG study]4.3950527
GSM549128patient 025, cancer, homogenized [OPG study]4.1312220
GSM549103patient 117, normal, homogenized [OPG study]4.2781522
GSM549117patient 073, normal, homogenized [OPG study]4.5872232
GSM549138patient 041, cancer, homogenized [OPG study]4.0216617
GSM549141patient 045, cancer, homogenized [OPG study]4.1743122
GSM549130patient 028, cancer, homogenized [OPG study]4.4817528
GSM549101patient 111, normal, homogenized [OPG study]4.4886428
GSM549105patient 128, normal, homogenized [OPG study]4.2972324
GSM549106patient 134, normal, homogenized [OPG study]4.2257523
GSM549112patient 048, normal, homogenized [OPG study]4.3363525
GSM549125patient 011, cancer, homogenized [OPG study]4.0935818
GSM549127patient 024, cancer, homogenized [OPG study]4.0855319
GSM549135patient 035, cancer, homogenized [OPG study]4.2384424